There’s pain. Then there’s Sword Health. And the difference is about $3,177 a year, per member. Not in theory, in ROI. In a world full of band-aid solutions and healthtech hype, Sword has built a biomechanical masterpiece that doesn’t just treat the pain, it chokes it out at the root.
Founded by Virgílio Bento, a biomedical engineer turned CEO with a PhD in spine-bending problems, Sword started in Portugal with a mission stitched together from clinical grit and code. His co-founder Márcio Colunas brought the algorithmic muscle, crafting motion sensor AI systems that read your movements like a lie detector at a poker table. From digital rehab startup to global digital health contender, this duo engineered a platform that now spans six continents and disrupts three verticals at once: musculoskeletal, pelvic, and mental health.
Today, they just bagged $40 million in fresh Series A funding, after a $30M Series E last year and $163M Series D in 2021. When a company raises its Series A after its Series E, it’s not a typo. It’s a flex. General Catalyst leads the round, with continued conviction from Khosla Ventures and Comcast Ventures, and fresh backing from Lince Capital, Armilar, Indico, Oxy Capital, and Shilling.
This round values Sword at $4 billion, and it’s not just about valuation theater. The numbers cut deep: 6.5 million AI-guided sessions, over $1B saved in unnecessary healthcare spend, 833% employer growth, 1,400 clients served, including more than 10% of the Fortune 50. If you’re a self-insured employer and you haven’t called Sword yet, the question isn’t if you’re behind. It’s how far.
The platform pairs Phoenix, Sword’s conversational AI care specialist, with a hybrid clinical team and an FDA-listed wearable device that makes your Apple Watch look like a happy meal toy. They’re scaling globally, expanding into cardiovascular and speech therapy, and dropping new preventive care modules like mixtapes.
CFO Valentina Longo, CMO Michael Krueger, CCO Kyle Spackman, CTO Jorge Meireles, and Dr. Vijay Yanamadala are building a system that’s HIPAA tight, cloud native, and already live in 150+ countries. It’s infrastructure with IQ, patents with purpose, and clinical outcomes that move markets.
Big congrats to the founders, the Sword Health team, and the investors betting on healthcare that actually works. You don’t scale from Portugal to global enterprise dominance on slogans. You do it with relentless focus, deep science, and AI that knows the human body better than most humans do.
This isn’t just another round. It’s a precision move in a market projected to hit $1.6T by 2032. Sword Health isn’t playing defense. They’re building the offense for the next decade of digital care.
